Giannitto Caterina, Mercante Giuseppe, Ammirabile Angela, Cerri Luca, De Giorgi Teresa, Lofino Ludovica, Vatteroni Giulia, Casiraghi Elena, Marra Silvia, Esposito Andrea Alessandro, De Virgilio Armando, Costantino Andrea, Ferreli Fabio, Savevski Victor, Spriano Giuseppe, Balzarini Luca
Department of Diagnostic Radiology, IRCCS Humanitas Research Hospital, Milan, Italy.
Department of Biomedical Sciences, Humanitas University, Milan, Italy.
Head Neck. 2023 Feb;45(2):482-491. doi: 10.1002/hed.27239. Epub 2022 Nov 8.
Machine learning (ML) is increasingly used to detect lymph node (LN) metastases in head and neck (H&N) carcinoma. We systematically reviewed the literature on radiomic-based ML for the detection of pathological LNs in H&N cancer. A systematic review was conducted in PubMed, EMBASE, and the Cochrane Library. Baseline study characteristics and methodological quality items (modeling, performance evaluation, clinical utility, and transparency items) were extracted and evaluated. The qualitative synthesis is presented using descriptive statistics. Seven studies were included in this study. Overall, the methodological quality items were generally favorable for modeling (57% of studies). The studies were mostly unsuccessful in terms of transparency (85.7%), evaluation of clinical utility (71.3%), and assessment of generalizability employing independent or external validation (72.5%). ML may be able to predict LN metastases in H&N cancer. Further studies are warranted to improve the generalizability assessment, clinical utility evaluation, and transparency items.
机器学习(ML)越来越多地用于检测头颈(H&N)癌中的淋巴结(LN)转移。我们系统地回顾了基于放射组学的ML在检测H&N癌病理性LN方面的文献。在PubMed、EMBASE和Cochrane图书馆进行了系统回顾。提取并评估了基线研究特征和方法学质量项目(建模、性能评估、临床效用和透明度项目)。使用描述性统计进行定性综合分析。本研究纳入了七项研究。总体而言,方法学质量项目在建模方面普遍良好(57%的研究)。这些研究在透明度(85.7%)、临床效用评估(71.3%)以及采用独立或外部验证的可推广性评估(72.5%)方面大多未成功。ML或许能够预测H&N癌中的LN转移。有必要进行进一步研究以改善可推广性评估、临床效用评估和透明度项目。
Cochrane Database Syst Rev. 2018-2-6
Health Technol Assess. 2006-9
Cochrane Database Syst Rev. 2018-1-16
Cochrane Database Syst Rev. 2018-1-22
Cochrane Database Syst Rev. 2005-7-20
Prostate Cancer Prostatic Dis. 2023-9